Rigid films and foils specialist Bilcare Research is investing in the expansion of its manufacturing site in Staufen, Germany.
The proposed expansion forms a part of the company’s strategy to cater to the customer demand for its products.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Work under the €15m expansion includes the installation of a extrusion-line and stenter-line at the facility.
The company will purchase two main aggregates from SML Maschinengesellschaft of Lenzing, Austria, and Brückner Maschinenbau of Siegsdorf, Germany.
Expected to create 15 new jobs, the project will also see the construction of a new stenter-hall and supporting infrastructure.
Bilcare Research Speciality Films Solutions global business unit head and managing director Thomas Piwowarsky said: "We are already planning for Q1-2016 with the new capacity and are looking forward to a further development of our business together with our customers and partners."
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataLast year, the facility was equipped with a new slitter to produce PVC films for special applications and thermoforming, as part of the company’s plans to optimise its global manufacturing network.
The production was moved from the Weißandt-Gölzau facility that was closed earlier this year, putting 57 jobs at risk.
Bilcare Research, along with Bilcare Global Clinical Supplies and Bilcare Technologies, is a part of Bilcare Research Group. It operates seven units across the world where it manufactures rigid films and foils for the pharmaceutical, security and credit card, printing and labeling sectors.
Bilcare Research employs close to 1,200 people.
